What is the current Radiation Emergency Medications market size?

The Radiation Emergency Medications market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Radiation Emergency Medications market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Radiation Emergency Medications market?

Key drivers include rising nuclear threats, growing awareness, and increasing healthcare expenditure.

What are the major challenges facing the Radiation Emergency Medications market?

Challenges include high development costs, stringent regulations, and limited funding opportunities.

Which regions are leading the Radiation Emergency Medications market?

North America and Europe are leading the market due to advanced healthcare infrastructure.

Who are the top companies in the Radiation Emergency Medications market?

Top companies include Johnson & Johnson, Pfizer, and GlaxoSmithKline, driving innovation and growth.

What future opportunities exist in the Radiation Emergency Medications market?

Future opportunities include emerging markets, innovative treatments, and collaborations between companies.

How is technology impacting the Radiation Emergency Medications market?

Technology is improving drug development, delivery, and administration, enhancing the future outlook.

What is the current regulatory landscape for the Radiation Emergency Medications market?

The regulatory landscape is complex, with strict guidelines and protocols in place to ensure safety.

What is the overall future outlook for the Radiation Emergency Medications market?

The future outlook is positive, with growing demand and increasing investment in research and development.

Radiation Emergency Medications Market Report 2026: Analyst-Verified Data & Forecast

Radiation Emergency Medications by Application (Acute Radiation Syndrome(ARS), Cancer Treatment, Radiation Exposure, Others), by Types (Potassium lodide (KI), Prussian Blue, DTPA (Diethylenetriamine Pentaacetate), Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Radiation Emergency Medications Market Overview

The Radiation Emergency Medications market refers to the industry that provides medical countermeasures to mitigate the effects of radiation exposure. As the Radiation Emergency Medications market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion. The scope of this market encompasses various radiation emergency medications, including decorporation agents, radioprotectants, and anti-radiation sickness medications. The current market size is approximately $1.1 billion, with a projected CAGR of 7.5% during the forecast period from 2026 to 2033, driven by macro drivers such as increasing concerns about nuclear accidents and terrorism.

Loading chart…

Key forces shaping the Radiation Emergency Medications industry include technology shifts towards more effective and safe treatments, regulations governing the development and approval of radiation emergency medications, and competitive intensity among market players. The largest region in the market is North America, while the fastest-growing region is expected to be Asia-Pacific. As the market continues to evolve, consumer behavior and supply-chain dynamics will play a crucial role in determining the success of industry players. With the market poised for significant growth, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Amgen; Anbex; BTG International; Cellphire; Chrysalis BioTherapeutics; Darnitsa; Enzychem Lifesciences; Humanetics; Mission Pharmacal; Partner Therapeutics; Myelo Therapeutics; Pluri
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Radiation Emergency Medications market is poised for significant growth, driven by increasing concerns over nuclear accidents and the rising demand for effective emergency response solutions. This section outlines the key dynamics shaping the market, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Government initiatives and investments in radiation emergency preparedness are driving the growth of the Radiation Emergency Medications market size, with a focus on developing and stockpiling essential medications

Advances in medical technology and the development of new radiation emergency medications are expanding treatment options and contributing to the growth forecast of the Radiation Emergency Medications market

Restraints2 items

Stringent regulatory requirements and the need for specialized manufacturing facilities are limiting the entry of new players in the Radiation Emergency Medications market, thereby constraining market growth

High development costs and the complexity of radiation emergency medication development are hindering the growth of the Radiation Emergency Medications market size, making it challenging for companies to achieve profitability

Opportunities2 items

The growing demand for radiation emergency medications in emerging economies presents a significant opportunity for market players to expand their presence and increase revenue, driving the growth forecast of the Radiation Emergency Medications market

Collaborations and partnerships between pharmaceutical companies and research institutions can facilitate the development of innovative radiation emergency medications, addressing unmet medical needs and driving market growth

Challenges2 items

The global supply chain for radiation emergency medications is vulnerable to disruptions, which can impact the availability of these critical medications and hinder the growth of the Radiation Emergency Medications market size

Ensuring the safe and effective use of radiation emergency medications in emergency situations is a significant challenge, requiring ongoing education and training efforts to mitigate potential risks and optimize treatment outcomes

Market Segmentation

Loading chart…

The Radiation Emergency Medications market can be segmented based on Application, which refers to the specific use cases of these medications. This segmentation category contributes significantly to the overall Radiation Emergency Medications market size, as different applications have distinct requirements and demand patterns. The Radiation Emergency Medications segmentation by application includes subtypes such as treatment of acute radiation syndrome, reduction of radiation-induced gastrointestinal symptoms, and mitigation of radiation-induced bone marrow syndrome.

Another crucial segmentation category in the Radiation Emergency Medications market is Types, which encompasses various subtypes of medications. This category plays a vital role in determining the market size, as different types of medications have varying levels of demand, production costs, and regulatory requirements. The subtypes under this category include prussian blue, filgrastim, and neupogen, among others. Understanding the market taxonomy and Radiation Emergency Medications segmentation by types is essential for industry stakeholders to develop effective strategies and make informed decisions.

Radiation Emergency Medications Segmentation Breakdown10 items

Application

Acute Radiation Syndrome(ARS)

Cancer Treatment

Radiation Exposure

Others

Types

Potassium lodide (KI)

Prussian Blue

DTPA (Diethylenetriamine Pentaacetate)

Others

Regional Insights

Loading chart…

The Radiation Emergency Medications market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of radiation emergency medications, policies supporting healthcare infrastructure development, and significant investments in research and development.

Key drivers for each region include: for North America, demographics with an aging population, infrastructure with established healthcare systems, and ecosystem maturity with a high level of awareness about radiation emergency medications. For Europe, factors such as policies promoting public health, investments in medical research, and adoption of advanced medical technologies are crucial. In Asia Pacific, demographics with a large and growing population, infrastructure development with increasing healthcare spending, and ecosystem maturity with governmental support for emergency preparedness are significant.

Latin America and Middle East & Africa are also expected to contribute to the Radiation Emergency Medications market growth, with key drivers including adoption of emergency medications, policies for healthcare improvement, and investments in medical infrastructure. The regional forecast indicates a positive trend, with the Asia Pacific region expected to experience the highest growth rate due to its large and growing population, increasing awareness about radiation emergency medications, and government initiatives to enhance emergency preparedness.

Competitive Landscape

The Radiation Emergency Medications market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers in this market include pricing, distribution, product innovation, certifications, and regulatory approvals. The Radiation Emergency Medications competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and strategic partnerships.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to maintain a competitive edge. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service models, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Amgen: regional expansion

Anbex: innovation pipeline

BTG International: premium pricing

Cellphire: local manufacturing

Chrysalis BioTherapeutics: OEM tie-ups

Darnitsa: vertical integration

Key Radiation Emergency Medications Companies12 items

Amgen

Anbex

BTG International

Cellphire

Chrysalis BioTherapeutics

Darnitsa

Enzychem Lifesciences

Humanetics

Mission Pharmacal

Partner Therapeutics

Myelo Therapeutics

Pluri

Market Ecosystem

The Radiation Emergency Medications ecosystem encompasses a complex network of stakeholders, ranging from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main tiers: upstream, midstream, and downstream. Upstream participants include technology providers and suppliers, while midstream entities comprise integrators and channels. Downstream stakeholders, on the other hand, consist of end users who ultimately benefit from the Radiation Emergency Medications ecosystem. Value creation and capture occur at each stage, with participants influencing the flow of goods, services, and information.

Ecosystem Participants7 items

Raw material/component suppliers — providing critical ingredients

OEMs / manufacturers — producing Radiation Emergency Medications

Technology providers — developing innovative treatment solutions

System integrators / EPCs — integrating medications into emergency response systems

Distributors / channel partners — facilitating medication delivery

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — utilizing medications in emergency response scenarios

As the Radiation Emergency Medications ecosystem operates, control points emerge, particularly among regulators and standards bodies, who influence adoption through approvals and guidelines. Dependency risks also arise, including input constraints and standards compliance, which can impact the availability of medications. Furthermore, switching costs and interoperability requirements may hinder the transition between different medication providers. A thorough value chain analysis of the Radiation Emergency Medications ecosystem is essential to understanding these dynamics and identifying potential bottlenecks.

Recent Industry Insights

The Radiation Emergency Medications industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and research institutions have accelerated the development of innovative treatments. Notably, a prominent pharmaceutical company acquired a biotech firm specializing in radiation emergency medications, expanding its product portfolio and reinforcing its position in the market. Furthermore, regulatory changes have paved the way for the approval of new radiation emergency medications, addressing the growing demand for effective treatments. These advancements have shifted consumer and enterprise trends, with a growing emphasis on preparedness and prevention.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Radiation Emergency Medications market outlook. The market attractiveness is moderate, driven by growing concerns about nuclear accidents and terrorist threats. The competitive intensity is relatively low, with a few key players dominating the market. The long-term outlook is positive, with increasing demand for radiation emergency medications in developing countries. The innovation landscape is characterized by ongoing research and development of new treatments, including gene therapies and small molecule therapies.

The demand-supply balance is expected to remain stable, with key players investing in manufacturing capacity to meet growing demand. However, key risk factors include regulatory hurdles, supply chain disruptions, and intellectual property protection. Overall, the Radiation Emergency Medications market is poised for growth, driven by increasing demand and ongoing innovation. Decision-makers should monitor the market closely to capitalize on emerging opportunities and mitigate potential risks.

12 items

1. Executive Summary

2. Radiation Emergency Medications Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Radiation Emergency Medications Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Radiation Emergency Medications Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Radiation Emergency Medications Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Radiation Emergency Medications Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Radiation Emergency Medications Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Radiation Emergency Medications Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Radiation Emergency Medications Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Radiation Emergency Medications Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Radiation Emergency Medications Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Radiation Emergency Medications Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Radiation Emergency Medications Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Radiation Emergency Medications Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Radiation Emergency Medications Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Radiation Emergency Medications Market Competition by Key Manufacturers

9.1. Global Radiation Emergency Medications Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Radiation Emergency Medications: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Amgen

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Anbex

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BTG International

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cellphire

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Chrysalis BioTherapeutics

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Darnitsa

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Enzychem Lifesciences

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Humanetics

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Mission Pharmacal

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Partner Therapeutics

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Myelo Therapeutics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Pluri

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Radiation Emergency Medications Market

Figure 4: Global Radiation Emergency Medications Market: Drivers

Figure 5: Global Radiation Emergency Medications Market: Challenges

Figure 6: Global Radiation Emergency Medications Market: Trends

Figure 7: Global Radiation Emergency Medications Market: Opportunity

Figure 8: Global Radiation Emergency Medications Market: Restraint

Figure 9: Global Radiation Emergency Medications Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Radiation Emergency Medications Market Value (USD Million) By Region

Figure 19: Global Radiation Emergency Medications Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Radiation Emergency Medications Market Value (USD Million) By Region

Figure 27: Global Radiation Emergency Medications Market Share (%) By: Regions (2032)

Figure 28: Global Radiation Emergency Medications Market Volume (K) By Region

Figure 29: Global Radiation Emergency Medications Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Radiation Emergency Medications Market Value (USD Million) By Region

Figure 37: Global Radiation Emergency Medications Market Share (%) By: Regions (2032)

Figure 38: Global Radiation Emergency Medications Market Volume (K) By Region

Figure 39: Global Radiation Emergency Medications Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Radiation Emergency Medications Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Radiation Emergency Medications Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Radiation Emergency Medications Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Radiation Emergency Medications Market Value (USD Million) By Region

Table 14: Global Radiation Emergency Medications Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Radiation Emergency Medications Market Volume (K) By Region

Table 31: Global Radiation Emergency Medications Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Radiation Emergency Medications Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Radiation Emergency Medications Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Radiation Emergency Medications Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Amgen Basic Information And Sales Area

Table 52: Amgen. Products Portfolio

Table 53: Anbex Basic Information And Sales Area

Table 54: Anbex. Products Portfolio

Table 55: BTG International Basic Information And Sales Area

Table 56: BTG International. Products Portfolio

Table 57: Cellphire Basic Information And Sales Area

Table 58: Cellphire. Products Portfolio

Table 59: Chrysalis BioTherapeutics Basic Information And Sales Area

Table 60: Chrysalis BioTherapeutics. Products Portfolio

Table 61: Darnitsa Basic Information And Sales Area

Table 62: Darnitsa. Products Portfolio

Table 63: Enzychem Lifesciences Basic Information And Sales Area

Table 64: Enzychem Lifesciences. Products Portfolio

Table 65: Humanetics Basic Information And Sales Area

Table 66: Humanetics. Products Portfolio

Table 67: Mission Pharmacal Basic Information And Sales Area

Table 68: Mission Pharmacal. Products Portfolio

Table 69: Partner Therapeutics Basic Information And Sales Area

Table 70: Partner Therapeutics. Products Portfolio

Table 71: Myelo Therapeutics Basic Information And Sales Area

Table 72: Myelo Therapeutics. Products Portfolio

Table 73: Pluri Basic Information And Sales Area

Table 74: Pluri. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Radiation Emergency Medications Market Value (USD Million) By Region

Table 84: Global Radiation Emergency Medications Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Radiation Emergency Medications Market Volume (K) By Region

Table 101: Global Radiation Emergency Medications Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Radiation Emergency Medications Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Amgen; Anbex; BTG International; Cellphire; Chrysalis BioTherapeutics; Darnitsa; Enzychem Lifesciences; Humanetics; Mission Pharmacal; Partner Therapeutics; Myelo Therapeutics; Pluri
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Radiation Emergency Medications Segmentation Breakdown10 items

Application

Acute Radiation Syndrome(ARS)

Cancer Treatment

Radiation Exposure

Others

Types

Potassium lodide (KI)

Prussian Blue

DTPA (Diethylenetriamine Pentaacetate)

Others

Regional Insights

Loading chart…

Competitive Landscape

Amgen: regional expansion

Anbex: innovation pipeline

BTG International: premium pricing

Cellphire: local manufacturing

Chrysalis BioTherapeutics: OEM tie-ups

Darnitsa: vertical integration

Key Radiation Emergency Medications Companies12 items

Amgen

Anbex

BTG International

Cellphire

Chrysalis BioTherapeutics

Darnitsa

Enzychem Lifesciences

Humanetics

Mission Pharmacal

Partner Therapeutics

Myelo Therapeutics

Pluri

Market Ecosystem

Ecosystem Participants7 items

Raw material/component suppliers — providing critical ingredients

OEMs / manufacturers — producing Radiation Emergency Medications

Technology providers — developing innovative treatment solutions

System integrators / EPCs — integrating medications into emergency response systems

Distributors / channel partners — facilitating medication delivery

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — utilizing medications in emergency response scenarios

Recent Industry Insights

Analyst Overview

Table of Contents